Research In Cancer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research in cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research In Cancer Today - Breaking & Trending Today

Dr Freedland on Treatment Suspension and HRQoL During the EMBARK Trial in nmHSPC

Stephen J. Freedland, MD, discusses the correlation between treatment suspension and HRQoL in patients with nmHSPC who were enrolled on the phase 3 EMBARK trial. ....

Stephenj Freedland , Department Of Urology , Research In Cancer , Samuel Oschin Comprehensive Cancer Institute , Integrated Research , Law Families Chair ,

Moving Treatments Earlier in Prostate Cancer Can Prevent Progression, Additional Treatment

Moving Treatments Earlier in Prostate Cancer Can Prevent Progression, Additional Treatment
ajmc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ajmc.com Daily Mail and Mail on Sunday newspapers.

United States , Stephen Freedland , American Urological Association , Research In Cancer , Integrated Research ,

Cedars-Sinai Experts Available for Interviews at American Urological Association Annual Meeting May 3-6

Physician-scientists from the Department of Urology at Cedars-Sinai will be attending the American Urological Association (AUA) Annual Meeting May 3-6 in San An ....

San Antonio , United States , Stephen Freedland , Timothy Daskivich , Shannon Smith , Hyung Kim , Department Of Urology At Cedars , Department Of Urology , American Urological Association , Academic Development , Urology Residency Training Program At Cedars , Research In Cancer , Annual Meeting May , World Report , Integrated Research , Cedars Sinai Cancer , Urologic Oncology , Urology Residency Training Program ,

Dr Freedland on the FDA Approval of Enzalutamide in nmCSPC

Stephen J. Freedland, MD, discusses the significance of the FDA approval of enzalutamide in nonmetastatic castration-sensitive prostate cancer. ....

Stephenj Freedland , Research In Cancer , Prevention Program , Department Of Urology , Samuel Oschin Comprehensive Cancer Institute , Warschaw Robertson Law Families Chair , Prostate Cancer , Integrated Research , Cancer Genetics , Cedars Sinai , Nonmetastatic Castration Sensitive Prostate Cancer ,

Enzalutamide Maintains HRQoL in High-Risk Recurrent nmCSPC - Renal and Urology News

Multiple surveys of patient-reported outcomes from the phase 3 EMBARK trial revealed no meaningful differences in pain progression or urinary symptoms and bowel symptoms or function over 205 weeks of follow-up. Enzalutamide does not worsen health-related quality of life compared with androgen deprivation therapy in patients with high-risk biochemically recurrence nmCSPC. ....

United States , Stephenj Freedland , Los Angeles , Society Of Urologic Oncology , Research In Cancer , European Organization For Research , Samuel Oschin Comprehensive Cancer Institute , Urologic Oncology , Integrated Research , Samuel Oschin Comprehensive Cancer , Brief Pain Inventory Short Form , Functional Assessment , Cancer Therapy Prostate , European Qol , European Organization , Cancer Qol Questionnaire Prostate ,